Ranizurel 0.5mg Injection
19,990 Per Vial
2 Vial (MOQ)
Razumab 10mg Injection
7,500 Per Piece
1 Vial (MOQ)
Razumab Injection is used for the treatment of eye diseases which are caused by diabetes, macular degeneration, and macular swelling. It reduces the abnormal growth and leakage of blood vessels in the eye that can cause vision loss. Razumab Injection is administered directly into the eyeball by an eye specialist. You should not self administer this medicine at home. The common side effects include conjunctival hemorrhage, eye pain, eye floaters, increased intraocular pressure, and eye inflammation. However, if you experience these side effects for a longer duration or any other symptoms which you think may be due to this medicine, please inform your doctor. It is not advised to drive after administration of this injection as it may cause blurring of vision. Uses of Razumab Injection Diabetic eye disease Wet age-related macular degeneration Macular edema due to retinal vein occlusion Benefits of Razumab Injection In Diabetic eye disease Diabetic eye disease is a group of eye problems seen in people with diabetes. It can lead to vision loss, weak eyesight or even blindness. Razumab Injection helps prevent this damage caused by diabetes and stops the worsening of vision. Consult your doctor if you have any doubts.In Wet age-related macular degenerationMacula is the part of the retina responsible for central vision. Wet age-related macular degeneration is an eye disorder that causes blurred vision or a blind spot in your visual field due to abnormal blood vessels that leak fluid or blood into the macula. This leads to vision problems. Razumab Injection helps prevent leakage of such abnormal blood vessels and therefore prevents vision loss. It is given as an injection by a doctor or nurse and should not be self-administered.In Macular edema due to retinal vein occlusionRetinal vein occlusion is a blockage of the small veins that carry blood away from the retina, which is that part of the eye that is responsible for vision. So, retinal vein occlusion often causes permanent damage to the retina and loss of vision. It can also lead to other eye problems. Sometimes there is a complete loss of vision almost immediately. Razumab Injection helps treat swelling of the macula that can cause vision disturbances. Side effects of Razumab Injection Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you're worried about them Common side effects of Razumab Conjunctival hemorrhage Eye pain Eye floaters Increased intraocular pressure Eye inflammation How to use Razumab Injection Your doctor or nurse will give you this medicine. Kindly do not self administer. How Razumab Injection works Razumab Injection is an anti-angiogenic medication. It works by blocking a protein called vascular endothelial growth factor (VEGF). This stops the growth and leakage of abnormal blood vessels in the eye(s) that may cause vision loss.
Best Deals from Ranibizumab Injection
Ranizu Rel Injection
18,000 Per Piece
1 Piece (MOQ)
0.0
Website
Authentic Eylea Injection 40Mg
40,000 - 45,000 Per Piece
Product Description Product Description: Eylea (Aflibercept) Injection Eylea Aflibercept Injection is a widely recognized medication used for the treatment of various retinal conditions. It is administered as an injection directly into the eye and has demonstrated efficacy in managing conditions such as neovascular age-related macular degeneration (AMD), diabetic macular edema (DME), and macular edema following retinal vein occlusion (RVO). Each injection of Eylea contains Aflibercept as the active ingredient. Aflibercept is a recombinant fusion protein that binds to and inhibits vascular endothelial growth factor-A (VEGF-A) and placental growth factor (PlGF). By targeting these factors, Eylea helps reduce the growth of abnormal blood vessels in the retina and decreases fluid leakage, thereby preserving and improving visual acuity. Eylea injections are typically administered by a healthcare professional trained in ophthalmic procedures. The treatment regimen involves a series of injections, with the specific dosing and interval determined by the individual's condition and response to treatment. The medication is supplied in sterile vials, prepared and packaged to maintain its integrity and ensure patient safety. Each vial contains the required dose for a single injection. It is important to note that Eylea Aflibercept Injection is a prescription medication and should only be administered under the guidance and supervision of a qualified healthcare professional with expertise in ophthalmology. Regular follow-up appointments with an ophthalmologist are essential to monitor the treatment's effectiveness, assess any potential side effects or complications, and make any necessary adjustments to the treatment plan. In summary, Eylea Aflibercept Injection offers an effective therapeutic option for individuals with retinal conditions such as neovascular AMD, DME, and macular edema following RVO. With its targeted action and specialized administration, Eylea aims to improve vision and provide relief from the symptoms associated with these retinal disorders, under the care of a healthcare professional.
Ranibizumab Injection
67,400 - 68,900 Per Vial
1 Vial (MOQ)
Lucentis is a drug used to treat wet age-related macular degeneration (AMD). It is also used to treat diabetic eye disease and other problems of the retina. It is injected into the eye to help slow vision loss from these diseases. Lucentis is the brand name for the drug, which is called ranibizumab.Ranibizumab is a medication used to manage and treat neovascular age-related macular degeneration, macular edema following retinal vein occlusion, diabetic macular edema, myopic choroidal neovascularization, and diabetic retinopathy.LUCENTIS 0.5 mg (0.05 mL of 10 mg/mL LUCENTIS solution) is recommended to be initially administered by intravitreal injection once a month
0.0
View Profile
Ranibizumab Injection
8,700 Per Vial
0.0
View Profile
Ranibizumab Injection
Get Price Quote
LUCENTIS® (ranibizumab injection) is a recombinant humanized IgG1 kappa isotype monoclonal antibody fragment designed for intraocular use. Ranibizumab binds to and inhibits the biologic activity of human vascular endothelial growth factor A (VEGF-A). Ranibizumab, which lacks an Fc region, has a molecular weight of approximately 48 kilodaltons and is produced by an E. coli expression system in a nutrient medium containing the antibiotic tetracycline. Tetracycline is not detectable in the final product.
0.0
View Profile
Ranibizumab Injection
Get Price Quote
0.0
View Profile
Ranibizumab Injection 0.5 mg
Get Price Quote
100 Box (MOQ)
0.0
View Profile
Ranibizumab Injection
Get Price Quote
Ranibizumab Injection, tamsulosin pellets, Calcium Chloride Lumps
0.0
View Profile
Post Free Ad